D.B. Root & Company LLC Acquires Shares of 1,121 Thermo Fisher Scientific Inc. (TMO)

D.B. Root & Company LLC acquired a new stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 1,121 shares of the medical research company’s stock, valued at approximately $213,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of TMO. Veritas Asset Management LLP grew its position in shares of Thermo Fisher Scientific by 44.1% during the third quarter. Veritas Asset Management LLP now owns 3,503,259 shares of the medical research company’s stock worth $662,817,000 after buying an additional 1,072,500 shares in the last quarter. Meritage Group LP acquired a new stake in shares of Thermo Fisher Scientific during the third quarter worth approximately $201,383,000. Viking Global Investors LP acquired a new stake in shares of Thermo Fisher Scientific during the fourth quarter worth approximately $154,660,000. Investec Asset Management LTD grew its position in shares of Thermo Fisher Scientific by 28.0% during the third quarter. Investec Asset Management LTD now owns 2,173,381 shares of the medical research company’s stock worth $411,204,000 after buying an additional 475,970 shares in the last quarter. Finally, Cornerstone Investment Partners LLC grew its position in shares of Thermo Fisher Scientific by 89.8% during the fourth quarter. Cornerstone Investment Partners LLC now owns 802,374 shares of the medical research company’s stock worth $152,355,000 after buying an additional 379,703 shares in the last quarter. Institutional investors own 87.63% of the company’s stock.

In other news, CEO Marc N. Casper sold 40,000 shares of the business’s stock in a transaction on Thursday, March 22nd. The shares were sold at an average price of $210.16, for a total transaction of $8,406,400.00. Following the completion of the transaction, the chief executive officer now owns 334,622 shares of the company’s stock, valued at $70,324,159.52. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Gregory J. Herrema sold 33,327 shares of the business’s stock in a transaction on Friday, February 2nd. The shares were sold at an average price of $219.70, for a total transaction of $7,321,941.90. Following the transaction, the senior vice president now directly owns 60,471 shares of the company’s stock, valued at approximately $13,285,478.70. The disclosure for this sale can be found here. In the last three months, insiders have sold 88,827 shares of company stock valued at $19,012,672. Corporate insiders own 0.49% of the company’s stock.

A number of research firms have recently weighed in on TMO. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $240.00 price target for the company in a research report on Thursday. ValuEngine raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. Bank of America raised their price target on shares of Thermo Fisher Scientific from $235.00 to $250.00 and gave the stock a “buy” rating in a research report on Thursday, February 1st. Morgan Stanley raised their price target on shares of Thermo Fisher Scientific from $223.00 to $227.00 and gave the stock an “overweight” rating in a research report on Thursday, February 1st. Finally, Barclays raised their price target on shares of Thermo Fisher Scientific from $225.00 to $245.00 and gave the stock an “overweight” rating in a research report on Thursday, February 1st. One research analyst has rated the stock with a hold rating and seventeen have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $222.29.

TMO stock opened at $204.65 on Friday. The company has a market cap of $85,563.95, a price-to-earnings ratio of 36.54, a price-to-earnings-growth ratio of 1.56 and a beta of 1.15. The company has a quick ratio of 0.92, a current ratio of 1.34 and a debt-to-equity ratio of 0.74. Thermo Fisher Scientific Inc. has a 1-year low of $151.74 and a 1-year high of $226.44.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings data on Wednesday, January 31st. The medical research company reported $2.79 EPS for the quarter, topping analysts’ consensus estimates of $2.66 by $0.13. The firm had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $5.72 billion. Thermo Fisher Scientific had a net margin of 10.64% and a return on equity of 16.01%. The firm’s revenue was up 22.1% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.41 earnings per share. equities analysts forecast that Thermo Fisher Scientific Inc. will post 10.81 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Monday, April 16th. Stockholders of record on Thursday, March 15th will be issued a dividend of $0.17 per share. This is an increase from Thermo Fisher Scientific’s previous quarterly dividend of $0.15. The ex-dividend date of this dividend is Wednesday, March 14th. This represents a $0.68 annualized dividend and a dividend yield of 0.33%. Thermo Fisher Scientific’s payout ratio is 12.14%.

ILLEGAL ACTIVITY NOTICE: This story was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this story on another publication, it was illegally stolen and republished in violation of U.S. and international copyright legislation. The correct version of this story can be read at https://www.tickerreport.com/banking-finance/3295270/d-b-root-company-llc-acquires-shares-of-1121-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Criteo  Trading Down 7.6%
Criteo Trading Down 7.6%
H&E Equipment Services  Stock Price Down 13.7%
H&E Equipment Services Stock Price Down 13.7%
Alcoa  Shares Gap Up to $51.95
Alcoa Shares Gap Up to $51.95
Four Corners Property  Releases  Earnings Results, Misses Expectations By $0.09 EPS
Four Corners Property Releases Earnings Results, Misses Expectations By $0.09 EPS
WestRock  Given News Impact Score of 0.27
WestRock Given News Impact Score of 0.27
Mylan  Receiving Somewhat Favorable Media Coverage, Analysis Shows
Mylan Receiving Somewhat Favorable Media Coverage, Analysis Shows


© 2006-2018 Ticker Report. Google+.